Hi everyone! I am quite new in the field of regulatory affairs and I am facing the problem of QMS gap analysis to get FDA compliance for submission.
The company I work for produces active medical devices in the field of hemodinamics.
I have heard from colleagues that one of the requirements of the medical device risk management process for FDA is that the risk analysis be validated by a clinical physician in the field based in the US (our company is based in europe).
could you confirm or deny this requirement and possibly share the reference in the FDA guidelines or 21 CFR of this requirement that mention it?
Thank You very much for sharing
Giulia
The company I work for produces active medical devices in the field of hemodinamics.
I have heard from colleagues that one of the requirements of the medical device risk management process for FDA is that the risk analysis be validated by a clinical physician in the field based in the US (our company is based in europe).
could you confirm or deny this requirement and possibly share the reference in the FDA guidelines or 21 CFR of this requirement that mention it?
Thank You very much for sharing
Giulia